Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > Eastern France

Please find below news from Eastern France, Franche-Comté, Rhone-Alpes, Languedoc-Rousillon, Provence-Alpes-Cote d'Azur, as well as about organisations from these regions.

Total search results: 485 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
bioMérieux, Inc.. (7/23/14). "Press Release: bioMérieux Virtuo, the New Generation of Blood Culture System, Is CE-marked". Marcy l’Étoile. 2014-07-23
bioMérieux S.A.. (7/17/14). "Press Release: Second-Quarter 2014 Business Review – Solid Growth in First-half Sales ". Marcy l’Étoile. 2014-07-17
Innate Pharma S.A.. (6/24/14). "Press Release: Innate Pharma Raises 50 Million Euros in a Capital Increase Subscribed by Specialist Institutional Investors [Not for Canada, Australia or Japan]". Marseille. 2014-06-24
Innate Pharma S.A.. (6/19/14). "Press Release: Innate Pharma Launches a Capital Increase to Raise Up to 15% of Current Capital [Not for Canada, Australia or Japan]". Marseille. 2014-06-19
Provence Technologies. (6/2/14). "Press Release: Provence Technologies Acquires Synprosis". Marseille. 2014-06-02
bioMérieux S.A.. (5/28/14). "Press Release: The General Shareholders’ Meeting of bioMérieux Approves the Appointment of Two New Independent Directors". Marcy l’Étoile. 2014-05-28
Biovision (Fondation pour l’Universite de Lyon / Andrew Lloyd & Associates). (5/19/14). "Press Release: Biovision Presents Its Selection of 44 Promising Life Sciences Businesses and Projects". Lyon. 2014-05-19
Sartorius AG. (4/28/14). "Press Release: Sartorius Stedim Biotech Acquires Majority Stake in U.S. Start-up AllPure Technologies. Takeover Extends Sartorius Stedim Biotech Portfolio for Single-use Bioprocessing". Aubagne. 2014-04-28
Sartorius AG. (4/28/14). "Press Release: First-quarter Figures – Sartorius Stedim Biotech Off to a Good Start in 2014". 2014-04-28
bioMérieux S.A.. (4/23/14). "Press Release: First-quarter 2014 Business Review". Marcy l’Étoile. 2014-04-23
bioMérieux S.A.. (4/15/14). "Press Release: Alexandre Mérieux Assumes Role of bioMérieux CEO". Marcy l’Étoile. 2014-04-15
TxCell S.A.. (4/14/14). "Press Release: TxCell Completes IPO on Euronext, Raising EUR 16.2 Million [only for relevant persons]". Valbonne. 2014-04-14
AbCheck s.r.o.. (4/2/14). "Press Release: AbCheck Antibody Discovery Deal with Pierre Fabre". Plzen. 2014-04-02
Adocia S.A.. (3/25/14). "Adocia Announces Financial Results for 2013. A Cash Position of EUR 19.4M at End of December 2013". Lyon. 2014-03-25
Transgene S.A.. (3/24/14). "Press Release: Transgene Successfully Completes Rights Issue and Private Placement. Total of €65.5 Million Raised [Not for distribution in or into Canada, Japan or Australia]". Strasbourg. 2014-03-24
Adocia S.A.. (3/20/14). "Press Release: Adocia Confirms Positive Clinical Results for Its BioChaperone Combo, a Combination of Long-acting Insulin Glargine and Fast-acting Insulin Lispro". Lyon. 2014-03-20
bioMérieux S.A.. (3/19/14). "Press Release: 2013 Financial Results". Marcy l’Étoile. 2014-03-19
PPF Group N.V.. (3/13/14). "Press Release: PPF Group Expands in the Field of Biotechnology and Immunotherapy". Amsterdam. 2014-03-13
Ynsect S.A.. (3/4/14). "Press Release: Ynsect Raises 1.8 Million Euro in Series A Funding to Develop Insect Biorefineries". 2014-03-04
Transgene S.A.. (2/28/14). "Press Release: Transgene Launches a Rights Issue of 45.5 Million Euros at a Price of 10 Euros per Share [Not for distribution into Canada, Japan or Australia]". Strasbourg. 2014-02-28
Adocia S.A.. (2/27/14). "Press Release: Adocia Announces Preliminary Positive Clinical Results for Its Combination of Long-acting Insulin Glargine and Fast-acting Insulin Analog Lispro, BioChaperone Combo". Lyon. 2014-02-27
bioMérieux S.A.. (2/26/14). "Press Release: bioMérieux Strengthens Its Clostridium difficile Offer with the Launch of VIDAS C. difficile GDH". Marcy l’Étoile. 2014-02-26
Adocia S.A.. (2/18/14). "Press Release: Adocia – Annual Revenue of EUR 5.6 M in 2013. The cash position of the Company Amounts to EUR 19.4 M". Lyon. 2014-02-18
HBM Healthcare Investments Ltd.. (2/17/14). "Press Release: HBM Healthcare Investments Participates with EUR 20 Million in Financing Round of Advanced Accelerator Applications [Not for distribution in the USA, Canada, Japan or Australia]". Zug. 2014-02-17
Advanced Accelerator Applications S.A.. (2/17/14). "Press Release: Advanced Accelerator Applications Completes €41 Million Fund Raising". Saint-Genis-Pouilly. 2014-02-17
Biovision. (2/11/14). "Press Release: Biovision Will Explore Ways to Identify and Fund Disruptive Innovation in Healthcare – June 5 and 6 2014". Lyon. 2014-02-11
Innate Pharma S.A.. (2/11/14). "Press Release: Annual Results for 2013. Cash Position Strengthened to €41.3m as at December 31, 2013". Marseille. 2014-02-11
Cellectis S.A.. (2/4/14). "Press Release: Cellectis Grants genOway an Exlusive Sublicense for Its Homologous Recombination Technology in the Field of Genetically Modified Rodent Models". Paris. 2014-02-04
Sartorius AG. (1/28/14). "Press Release: Sartorius Stedim Biotech – Preliminary Results 2013". Göttingen. 2014-01-28
bioMérieux S.A.. (1/27/14). "Press Release: Appointment of Claire Giraut as bioMérieux's Corporate Vice President and Chief Financial Officer". Marcy L’Étoile. 2014-01-27
bioMérieux S.A.. (1/22/14). "Press Release: bioMérieux – Business Review for the Year ended December 31, 2013". Marcy L’Étoile. 2014-01-22
bioMérieux S.A.. (1/16/14). "Press Release: bioMérieux Finalizes Acquisition of the U.S. Company BioFire, Specialized in Molecular Biology". Marcy l’Étoile. 2014-01-16
Eurofins Scientific. (1/16/14). "Press Release: Eurofins Reinforces Its Pharmaceutical Quality Control Capability with the Acquisition of IDmyk". 2014-01-16
Adocia S.A.. (12/9/13). "Press Release: Adocia Signs an Exclusive License on a Nanotechnology which Improves the Efficacy of Anti-tumoral Agents by Targeting Their Action into Tumors". Lyon. 2013-12-09
bioMérieux S.A.. (12/5/13). "Press Release: bioMérieux Is Moving Forward to a New Molecular Biology Workflow Solution for Reference or Centralized Laboratories". Marcy l’Étoile. 2013-12-05
Biocartis S.A.. (11/28/13). "Press Release: Biocartis Announces the End of Its Alliance with bioMérieux". Mechelen & Lausanne. 2013-11-28
bioMérieux S.A.. (11/28/13). "Press Release: bioMérieux Announces Termination of Its Collaboration with Biocartis in Molecular Biology". Marcy l’Étoile. 2013-11-28
Innate Pharma S.A.. (11/20/13). "Press Release: Innate Pharma Raises €20.3 Million in a Private Placement Subscribed Entirely by US-based Specialist Investors". Marseille. 2013-11-20
Innate Pharma S.A.. (11/18/13). "Press Release: Innate Pharma Has Launched a Private Placement to Raise about 18 Millions Euros". Marseille. 2013-11-18
Definiens AG. (10/28/13). "Press Release: Definiens Expands Management Team to Develop the Clinical Market". 2013-10-28
bioMérieux S.A.. (10/23/13). "Press Release: bioMérieux Business Review for the Nine Months Ended September 30, 2013". Marcy l’Étoile. 2013-10-23
Sartorius AG. (10/21/13). "Press Release: Nine-Month Figures 2013. Sartorius Stedim Biotech on Track Towards Reaching Its 2013 Targets". 2013-10-21
Hybrigenics S.A.. (10/11/13). "Press Release: Hybrigenics Acquires the Genomic Activities of Imaxio. Pradeyrol Development Invests EUR 1.3 Million in Hybrigenics". Paris. 2013-10-11
Skuldtech. (9/11/13). "Press Release: Skuldtech Secures EUR 1 Million to Develop New Diagnostics for Alzheimer’s Disease. Skuldtech and AB Science to Renew Their Collaboration Agreement". Montpellier. 2013-09-11
bioMérieux S.A.. (9/3/13). "Press Release: bioMérieux Makes a Significant Acquisition in Molecular Biology in the U.S. – With the Acquisition of BioFire, bioMérieux Consolidates Its Postition as Major Player in Infectious Disease Diagnostics". Marcy l’Ét 2013-09-03
bioMérieux S.A.. (9/3/13). "Press Release: bioMérieux – First-half 2013 Results". Marcy l’Étoile. 2013-09-03
Sartorius AG. (9/3/13). "Press Release: Sartorius Stedim Biotech Signs Long-term Syndicated Loan. Credit Volume at 250 Million Euros – International Bank Syndicate Led by Commerzbank and Nord/LB". Aubagne & Goettingen. 2013-09-03
Novartis AG. (9/2/13). "Press Release: Novartis’ Serelaxin (RLX030) Improved Symptoms and Mortality across Multiple Subgroups of Patients with Acute Heart Failure". Basel. 2013-09-02
bioMérieux S.A.. (8/21/13). "Press Release: bioMérieux Announces U.S. FDA Clearance for VITEK MS, a Revolutionary Technology which Reduces Microbial Identification from Days to Minutes Reinforcing Medical Value of Diagnostics". Marcy l’Étoile & Durham, N 2013-08-21
Adocia S.A.. (7/29/13). "Press Release: Adocia Reacquires Exclusive Development Rights to Ultra-fast Acting Insulin Analog. Adocia and Lilly Terminate Collaboration". Lyon. 2013-07-29
Sartorius AG. (7/23/13). "Press Release: Sartorius Stedim Biotech. Strong Growth Momentum in the First Half of 2013". 2013-07-23
bioMérieux S.A.. (7/18/13). "Press Release: First-half 2013 Business Review". Marcy l’Étoile. 2013-07-18
bioMérieux S.A.. (6/27/13). "Press Release: International Experts Join Forces against Suberbugs at the 4th World Forum on Healthcare-associated Infections and Antimicrobial Resistance. bioMérieux Commits to Supporting Expert-defined Global Priorities". M 2013-06-27
bioMérieux S.A.. (6/20/13). "Press Release: bioMérieux Receives CE Marking for VIDAS 3, the New Generation of VIDAS". Marcy l’Étoile. 2013-06-20
PX’Therapeutics S.A.. (6/14/13). "Press Release: PX'Therapeutics Announces Appointment of New CEO". 2013-06-14
bioMérieux S.A.. (5/30/13). "Press Release: bioMérieux Receives FDA Approval for THxID-BRAF Companion Diagnostic Test". Marcy l’Étoile. 2013-05-30
Cytoo S.A.. (5/24/13). "Press Release: Marc Le Bozec Joins Cytoo as Chief Executive Officer". Grenoble. 2013-05-24
bioMérieux S.A.. (5/21/13). "Press Release: Nicolas Cartier Appointed Corporate Vice President, Industrial Microbiology Unit of bioMérieux". Marcy l’Étoile. 2013-05-21
ElsaLys Biotech S.A.S.. (5/17/13). "Press Release: The Start-up ElsaLys Biotech, a New Player in the Therapeutic Monoclonal Antibody Arena, Announces the First Round of Financing with Transgene and Sofimac Partners". Lyon & Ilkirch-Graffenstaden. 2013-05-17
Sartorius AG. (4/23/13). "Press Release: First-quarter Figures – SSB Group Continues on the Growth Track. Further Growth in Order Intake and Sales Revenue". Göttingen. 2013-04-23
bioMérieux S.A.. (4/23/13). "Press Release: bioMérieux – First-quarter 2013 Business Review". Marcy l’Étoile. 2013-04-23
Seegene, Inc.. (4/15/13). "Press Release: Seegene Signs New License Agreement for DPO and TOCE Technologies". Gaithersburg, MD & Seoul. 2013-04-15
bioMérieux S.A.. (3/25/13). "Press Release: Veolia Environnement and bioMérieux Initiate a Resarch Partnership to Develop an Innovative Monitoring System for Drinking Water Quality". Paris & Lyon. 2013-03-25
Cytoo S.A.. (3/18/13). "Press Release: Olivier Pasquier Joins Cytoo as Chief Commercial Officer". Grenoble. 2013-03-18
Leco Corporation. (3/13/13). "Press Release: European GCxGC Symposium Scheduled for September". St. Joseph, MI. 2013-03-13
bioMérieux S.A.. (3/13/13). "Press Release: 2012 Financial Results". Marcy l’Étoile. 2013-03-13
EyeTechCare S.A.. (3/12/13). "Press Release: EyeTechCare Raises EUR Ten Million in a Third Round of Funding". Rillieux-la-Pape. 2013-03-12
Creabilis S.A.. (2/28/13). "Press Release: Creabilis Appoints Catherine Moukheibir to Its Board of Directors". Luxembourg. 2013-02-28
Analytical Pixels Technology S.A.S. (APIX). (2/14/13). "Press Release: APIX Technology Introduces Industry’s First Gas Chromatography Device Based on Silicon Nano-scale Components". Grenoble. 2013-02-14
Analytical Pixels Technology S.A.S. (APIX). (2/7/13). "Press Release: APIX Technology Signs a Comprehensive IP Licensing Agreement with CEA-Leti and Caltech. APIX Secures Rights to Industry Leading Nano-scale Sensor Technology". Grenoble. 2013-02-07
Alizé Pharma. (1/3/13). "Press Release: Alizé Pharma Launches the PREMAG Research Program". Lyon. 2013-01-03
Poxel S.A.. (12/18/12). "Press Release: Poxel Raises €13 Million to Progress Imeglimin Development to Treat Type 2 Diabetes". Lyon. 2012-12-18
bioMérieux S.A.. (12/4/12). "Press Release: bioMérieux Opens a Subsidiary in Vietnam, Strengthening Its Footprint in High-growth Southeast Asia". Marcy l’Étoile. 2012-12-04
Ipsogen S.A.. (11/29/12). "Press Release: Ipsogen to Be Renamed Qiagen Marseille on the First of January 2013. Results of the General Assembly of 14 November 2012 – Perspectives for 2013". Marseille. 2012-11-29
bioMérieux S.A.. (11/15/12). "Press Release: bioMérieux and Quanterix Sign Strategic Partnership in Ultrasensitive and Multiplex Immunoassays. Quanterix’s Simoa Technology to Be Developed for Diagnostic Applications". Marcy l’Étoile & Lexington, MA. 2012-11-15
Poxel S.A.. (11/5/12). "Press Release: Poxel’s Anti-diabetic Imeglimin Shows Significant Clinical Benefits in Type 2 Diabetes when Added to Sitagliptin. Phase II Study Achieved Primary and Secondary Endpoints". Lyon. 2012-11-05
Biom’Up S.A.. (10/25/12). "Press Release: Biom’Up Raises EUR 6.8 Million". Lyon. 2012-10-25
bioMérieux S.A.. (10/23/12). "Press Release: Business Review for the Nine Months Ended September 30, 2012". Marcy l’Étoile. 2012-10-23
PX’Therapeutics S.A.. (10/1/12). "Press Release: Aguettant, an Independent French Pharmaceutical Company, and PX'Therapeutics, a French Contract Manufacturing Organization Dedicated to the Development of Recombinant Proteins, Join Forces to Boost Their A 2012-10-01
Trophos S.A.. (9/18/12). "Press Release: Marceline Clementine Appointed Chief Financial Officer". Marseille. 2012-09-18
Boehringer Ingelheim. (8/27/12). "Press Release: Clinical Experience with Pradaxa Crosses One Million Patient-years of Treatment. 40,000 People Estimated to Be Saved from a Stroke Related to Non-valvular Atrial Fibrillation [For Non-US, Non-UK & Non-Cana 2012-08-27
GlaxoSmithKline plc. (8/3/12). "Press Release: Regulatory Update – GSK Announces Submissions in the EU and US for Dabrafenib and Trametinib". London. 2012-08-03
Trophos S.A.. (7/31/12). "Press Release: Trophos Announces Conclusion of MitoTarget Consortium, Achieving Advanced Understanding of Neurodegenerative Diseases". Marseille. 2012-07-31
Nicox S.A.. (7/27/12). "Press Release: NicOx First Half 2012 Financial Results". Sophia Antipolis. 2012-07-27
Trophos S.A.. (7/23/12). "Press Release: Trophos Appoints JSB Partners as Global Partnership Advisor. Life Science Advisor to Advise Trophos on Strategic Partnerships for Orphan Disease and Niche Indication Candidates". Marseille. 2012-07-23
Calixar S.A.S.. (7/5/12). "Press Release: Calixar and Synthelis Team Up to Provide Unique Membrane Protein Services". Lyon & Grenoble. 2012-07-05
Cytoo S.A.. (7/5/12). "Press Release: Cytoo and PharmaNest Are Launching the New 2D+ Cell Culture Platform". Grenoble. 2012-07-05
Agilent Technologies Inc.. (7/3/12). "Press Release: Agilent Technologies Names Imaxio as Certified Provider of Target Enrichment Services for Next-Gen Sequencing". Santa Clara, CA. 2012-07-03
Imaxio S.A.. (6/27/12). "Press Release: Imaxio Boosts Genomics Capacity with New Automated Equipment. Investment Means Larger Scale, Faster High Throughput Sequencing for Imaxio Customers". Clermont-Ferrand. 2012-06-27
Calixar S.A.S.. (6/18/12). "Press Release: Calixar Closes an Initial 875,000 Euro Funding Round. The Funds Will Enable the Lyon-based Membrane Protein Services Specialist to Develop Its International Business". Lyon. 2012-06-18
Cytheris S.A.. (6/12/12). "Press Release: Cytheris SA Appoints Damian Marron as Chief Executive Officer". Paris. 2012-06-12
Alizé Pharma. (6/4/12). "Press Release: Alizé Pharma Closes 3.3 Million Euro Funding Round". Lyon. 2012-06-04
OctoPlus N.V.. (4/16/12). "Press Release: OctoPlus Announces the Proposal to Appoint Catherine Moukheibir to the Supervisory Board". Leiden. 2012-04-16
ImaginAb, Inc.. (3/26/12). "Press Release: ImaginAb Concludes $12.5m Series A Financing". Los Angeles, CA. 2012-03-26
Nicox S.A.. (3/21/12). "Press Release: NicOx Enters into Option Agreement to Acquire Altacor as a First Step Towards Building an International Ophthalmology Business". Sophia Antipolis. 2012-03-21
Adocia S.A.. (3/15/12). "Press Release: Adocia Increase the Size of Its Initial Public Offering to €27.4 Million through the Partial Exercise of the Overallotment Option [Not to Be Published in United States of America, Canada, Australia , Italy or Japan 2012-03-15
Adocia S.A.. (2/14/12). "Press Release: Adocia Carris Out, with much Success, the First IPO of the Year on the NYSE Euronext Paris Regulated Market [This document may not be published, distributed or disseminated, directly or indirectly, in the United St 2012-02-14
Alizé Pharma. (2/2/12). "Press Release: Alizé Pharma Licenses Its Asparec Therapy for Treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma". Lyon. 2012-02-02
Qiagen N.V.. (1/31/12). "Press Release: Qiagen Reports Fourth Quarter and Full-year 2011 Results". Venlo. 2012-01-31
Vivalis S.A.. (1/23/12). "Press Release: Opening of a New Laboratory Dedicated to the Viva|Screen Antibody Discovery Platform". Nantes, Lyon & Toyama. 2012-01-23
next pagenext page 1 2 3 4 5  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top